Skip to main content

The Dow Jones Rallies After Gilead Drug Shows Promise in Treating COVID-19

The Dow Jones popped this morning on news that a drug from Gilead Sciences (NASDAQ: GILD) showed some effectiveness in treating patients with coronavirus. Shares of the drug company surged 16% after the bell on a report from a Chicago hospital that showed progress from Remdesivir. Read more... Tags: dow jones today To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2020 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post The Dow Jones Rallies After Gilead Drug Shows Promise in Treating COVID-19 appeared first on Money Morning - We Make Investing Profitable .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.